It is the foundation of several breakthrough medications that are revolutionizing the treatment of obesity and type 2 diabetes
This option is ideal for long-term body composition improvements
Molecular Psychiatry, 5(6), 616632
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Following rigorous quality control measures, which included the exclusion of duplicate entries, reports with incomplete demographic data (age or gender), and cases with missing temporal information, we retained 13,047 AE reports associated with concomitant GLP-1 receptor agonist and metformin therapy for final analysis
The rise in use of GLP-1 medications like Ozempic, Wegovy, and Mounjaro has been accompanied by a rise in online discourse around what it means to use them